| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 9.15e-10 | 15 | 65 | 5 | GO:0008020 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 1.88e-09 | 17 | 65 | 5 | GO:0009881 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OPN1MW2 PROKR1 VN1R5 OPN1MW3 CELSR1 DRD5 OXTR MAS1L AVPR1A AVPR1B AGTR2 OR52N4 RRH OPN1LW GPR135 GPR143 OPN1MW | 2.09e-09 | 884 | 65 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OPN1MW2 PROKR1 VN1R5 OPN1MW3 CELSR1 DRD5 OXTR MAS1L AVPR1A AVPR1B ABCC8 AGTR2 SCN7A OR52N4 RRH OPN1LW GPR135 GPR143 OPN1MW | 3.32e-08 | 1353 | 65 | 19 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.50e-07 | 133 | 65 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 3.55e-07 | 140 | 65 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | vasopressin receptor activity | 1.14e-06 | 7 | 65 | 3 | GO:0005000 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 2.17e-05 | 17 | 65 | 3 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 3.07e-05 | 19 | 65 | 3 | GO:0015373 | |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 3.12e-05 | 3 | 65 | 2 | GO:0005369 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 5.57e-05 | 23 | 65 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 8.11e-05 | 26 | 65 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 1.04e-04 | 5 | 65 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | angiotensin receptor activity | 1.04e-04 | 5 | 65 | 2 | GO:0001595 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 1.55e-04 | 6 | 65 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | dopamine binding | 2.17e-04 | 7 | 65 | 2 | GO:0035240 | |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid transmembrane transporter activity | 3.70e-04 | 9 | 65 | 2 | GO:0015185 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.45e-04 | 49 | 65 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.38e-04 | 125 | 65 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | catecholamine binding | 7.95e-04 | 13 | 65 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 8.95e-04 | 477 | 65 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.07e-03 | 15 | 65 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | symporter activity | 1.45e-03 | 150 | 65 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.49e-03 | 151 | 65 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 1.72e-03 | 19 | 65 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | amino acid binding | 1.74e-03 | 73 | 65 | 3 | GO:0016597 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.34e-03 | 171 | 65 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.34e-03 | 171 | 65 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.34e-03 | 81 | 65 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 2.53e-03 | 23 | 65 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.16e-03 | 90 | 65 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 4.00e-03 | 29 | 65 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | BSND SLC6A6 ABCG4 SLC6A13 ABCA2 SLC12A1 SLC6A16 TSPO2 ABCC8 SCN7A | 4.60e-03 | 1180 | 65 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.87e-03 | 105 | 65 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.41e-03 | 109 | 65 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 5.79e-03 | 35 | 65 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | fibronectin binding | 6.80e-03 | 38 | 65 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 6.89e-03 | 119 | 65 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | transporter activity | BSND SLC6A6 ABCG4 SLC6A13 ABCA2 SLC12A1 SLC6A16 TSPO2 ABCC8 SCN7A | 8.44e-03 | 1289 | 65 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 8.65e-03 | 43 | 65 | 2 | GO:0015036 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by vasopressin | 3.94e-10 | 5 | 63 | 4 | GO:0001992 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | SLC6A6 SLC6A13 ABCA2 DRD5 OXTR AVPR1A AVPR1B ABCC8 AGTR2 VEGFA | 8.53e-08 | 344 | 63 | 10 | GO:0003018 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by hormone | 4.77e-07 | 51 | 63 | 5 | GO:0001990 | |
| GeneOntologyBiologicalProcess | phototransduction | 5.80e-07 | 53 | 63 | 5 | GO:0007602 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OPN1MW2 PROKR1 VN1R5 OPN1MW3 CELSR1 DRD5 OXTR MAS1L AVPR1A AVPR1B AGTR2 OR52N4 RRH OPN1LW GPR135 GPR143 OPN1MW | 6.04e-07 | 1395 | 63 | 17 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of visible light | 8.38e-07 | 57 | 63 | 5 | GO:0009584 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 1.18e-06 | 61 | 63 | 5 | GO:0003044 | |
| GeneOntologyBiologicalProcess | circulatory system process | SLC6A6 SLC6A13 ABCA2 DRD5 OXTR AVPR1A AVPR1B ABCC8 LPA AGTR2 SCN7A VEGFA | 1.87e-06 | 733 | 63 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | detection of light stimulus | 3.77e-06 | 77 | 63 | 5 | GO:0009583 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 6.89e-06 | 87 | 63 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 7.29e-06 | 88 | 63 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | BSND GPI ABCG4 ABCA2 DRD5 MALRD1 SLC12A1 AVPR1A STXBP5L LIPG ABCC8 AGTR2 SCN7A VEGFA | 1.89e-05 | 1249 | 63 | 14 | GO:0048878 |
| GeneOntologyBiologicalProcess | amino acid transport | 2.87e-05 | 195 | 63 | 6 | GO:0006865 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 3.50e-05 | 202 | 63 | 6 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 3.50e-05 | 202 | 63 | 6 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 3.60e-05 | 203 | 63 | 6 | GO:0035150 | |
| GeneOntologyBiologicalProcess | endocrine process | 3.70e-05 | 123 | 63 | 5 | GO:0050886 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 3.85e-05 | 124 | 63 | 5 | GO:0003073 | |
| GeneOntologyBiologicalProcess | cellular response to light stimulus | 4.83e-05 | 130 | 63 | 5 | GO:0071482 | |
| GeneOntologyBiologicalProcess | negative regulation of blood-brain barrier permeability | 5.49e-05 | 4 | 63 | 2 | GO:1905604 | |
| GeneOntologyBiologicalProcess | visual perception | 7.20e-05 | 230 | 63 | 6 | GO:0007601 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 7.73e-05 | 233 | 63 | 6 | GO:0050953 | |
| GeneOntologyBiologicalProcess | acidic amino acid transport | 1.27e-04 | 84 | 63 | 4 | GO:0015800 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 1.34e-04 | 371 | 63 | 7 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 1.34e-04 | 371 | 63 | 7 | GO:0104004 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid import | 1.37e-04 | 6 | 63 | 2 | GO:0051939 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.38e-04 | 259 | 63 | 6 | GO:0006836 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.47e-04 | 648 | 63 | 9 | GO:0008015 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 1.60e-04 | 382 | 63 | 7 | GO:0009416 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.86e-04 | 173 | 63 | 5 | GO:0009581 | |
| GeneOntologyBiologicalProcess | sperm ejaculation | 1.91e-04 | 7 | 63 | 2 | GO:0042713 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 1.96e-04 | 175 | 63 | 5 | GO:0009582 | |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 2.18e-04 | 179 | 63 | 5 | GO:0032368 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 2.47e-04 | 410 | 63 | 7 | GO:0046942 | |
| GeneOntologyBiologicalProcess | alkanesulfonate transmembrane transport | 2.54e-04 | 8 | 63 | 2 | GO:0042918 | |
| GeneOntologyBiologicalProcess | taurine transmembrane transport | 2.54e-04 | 8 | 63 | 2 | GO:0015734 | |
| GeneOntologyBiologicalProcess | organic acid transport | 2.55e-04 | 412 | 63 | 7 | GO:0015849 | |
| GeneOntologyBiologicalProcess | positive regulation of cell division | 2.89e-04 | 104 | 63 | 4 | GO:0051781 | |
| GeneOntologyBiologicalProcess | lipid localization | 3.10e-04 | 565 | 63 | 8 | GO:0010876 | |
| GeneOntologyBiologicalProcess | cellular response to radiation | 3.16e-04 | 194 | 63 | 5 | GO:0071478 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 3.26e-04 | 9 | 63 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | regulation of blood-brain barrier permeability | 4.07e-04 | 10 | 63 | 2 | GO:1905603 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.35e-04 | 208 | 63 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 5.05e-04 | 215 | 63 | 5 | GO:1905952 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 5.09e-04 | 51 | 63 | 3 | GO:0055078 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 5.14e-04 | 121 | 63 | 4 | GO:0042310 | |
| GeneOntologyBiologicalProcess | female mating behavior | 5.94e-04 | 12 | 63 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | positive regulation of vasoconstriction | 6.03e-04 | 54 | 63 | 3 | GO:0045907 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokinesis | 6.36e-04 | 55 | 63 | 3 | GO:0032467 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 6.86e-04 | 230 | 63 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | mating behavior | 7.06e-04 | 57 | 63 | 3 | GO:0007617 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 7.43e-04 | 58 | 63 | 3 | GO:0089718 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | OPN1MW2 GPI OPN1MW3 DRD5 OXTR AVPR1A ABCC8 SCN7A RRH OPN1LW OPN1MW VEGFA | 7.48e-04 | 1361 | 63 | 12 | GO:0009628 |
| GeneOntologyBiologicalProcess | cholesterol transport | 7.54e-04 | 134 | 63 | 4 | GO:0030301 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 7.75e-04 | 358 | 63 | 6 | GO:0015850 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 7.81e-04 | 59 | 63 | 3 | GO:0045777 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 7.85e-04 | 237 | 63 | 5 | GO:0008217 | |
| GeneOntologyBiologicalProcess | response to radiation | 8.37e-04 | 503 | 63 | 7 | GO:0009314 | |
| GeneOntologyBiologicalProcess | sterol transport | 8.65e-04 | 139 | 63 | 4 | GO:0015918 | |
| GeneOntologyBiologicalProcess | lipid transport | 8.66e-04 | 506 | 63 | 7 | GO:0006869 | |
| GeneOntologyBiologicalProcess | motor neuron migration | 9.40e-04 | 15 | 63 | 2 | GO:0097475 | |
| GeneOntologyBiologicalProcess | organic anion transport | 9.60e-04 | 515 | 63 | 7 | GO:0015711 | |
| GeneOntologyBiologicalProcess | organic cation transport | 1.01e-03 | 145 | 63 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | regulation of alcohol biosynthetic process | 1.04e-03 | 65 | 63 | 3 | GO:1902930 | |
| GeneOntologyBiologicalProcess | insemination | 1.07e-03 | 16 | 63 | 2 | GO:0007320 | |
| GeneOntologyBiologicalProcess | enucleate erythrocyte differentiation | 1.07e-03 | 16 | 63 | 2 | GO:0043353 | |
| GeneOntologyBiologicalProcess | maternal behavior | 1.36e-03 | 18 | 63 | 2 | GO:0042711 | |
| GeneOntologyBiologicalProcess | behavior | 1.46e-03 | 891 | 63 | 9 | GO:0007610 | |
| GeneOntologyBiologicalProcess | reproductive behavior | 1.51e-03 | 74 | 63 | 3 | GO:0019098 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.52e-03 | 275 | 63 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound biosynthetic process | 1.57e-03 | 277 | 63 | 5 | GO:1901617 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 1.07e-06 | 26 | 63 | 4 | GO:0097381 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 2.12e-05 | 111 | 63 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | non-motile cilium | 2.74e-05 | 196 | 63 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 6.24e-05 | 139 | 63 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 9.82e-05 | 153 | 63 | 5 | GO:0097731 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 7.52e-04 | 59 | 63 | 3 | GO:0005637 | |
| HumanPheno | Blue cone monochromacy | 1.18e-05 | 2 | 18 | 2 | HP:0007939 | |
| HumanPheno | Cone monochromacy | 1.18e-05 | 2 | 18 | 2 | HP:0011517 | |
| HumanPheno | Reduced OCT-measured foveal thickness | 3.53e-05 | 3 | 18 | 2 | HP:0030619 | |
| HumanPheno | Abnormal retinal morphology on macular OCT | 5.47e-05 | 22 | 18 | 3 | HP:0030612 | |
| HumanPheno | Abnormal optical coherence tomography | 5.47e-05 | 22 | 18 | 3 | HP:0030603 | |
| HumanPheno | Abnormal OCT-measured foveal thickness | 7.05e-05 | 4 | 18 | 2 | HP:0030617 | |
| HumanPheno | Abnormal macular morphology | 1.10e-04 | 237 | 18 | 6 | HP:0001103 | |
| HumanPheno | Abnormal urine chloride concentration | 1.17e-04 | 5 | 18 | 2 | HP:0012600 | |
| HumanPheno | Hyperchloriduria | 1.17e-04 | 5 | 18 | 2 | HP:0002914 | |
| HumanPheno | Hyperprostaglandinuria | 1.75e-04 | 6 | 18 | 2 | HP:0003527 | |
| HumanPheno | Abnormal circulating prostaglandin circulation | 1.75e-04 | 6 | 18 | 2 | HP:0011023 | |
| HumanPheno | Hypochloremia | 2.45e-04 | 7 | 18 | 2 | HP:0003113 | |
| HumanPheno | Hyperactive renin-angiotensin system | 3.26e-04 | 8 | 18 | 2 | HP:0000841 | |
| HumanPheno | Abnormal foveal morphology on macular OCT | 3.26e-04 | 8 | 18 | 2 | HP:0030613 | |
| HumanPheno | Abnormal circulating unsaturated fatty acid concentration | 3.26e-04 | 8 | 18 | 2 | HP:0011022 | |
| HumanPheno | Abnormal circulating eicosanoid concentration | 3.26e-04 | 8 | 18 | 2 | HP:0030361 | |
| HumanPheno | Hypokalemic metabolic alkalosis | 4.18e-04 | 9 | 18 | 2 | HP:0001960 | |
| HumanPheno | Increased urinary potassium | 4.18e-04 | 9 | 18 | 2 | HP:0003081 | |
| HumanPheno | Pendular nystagmus | 4.79e-04 | 45 | 18 | 3 | HP:0012043 | |
| HumanPheno | Metamorphopsia | 4.79e-04 | 45 | 18 | 3 | HP:0012508 | |
| HumanPheno | Eccentric visual fixation | 5.22e-04 | 10 | 18 | 2 | HP:0025549 | |
| HumanPheno | Red-green dyschromatopsia | 6.37e-04 | 11 | 18 | 2 | HP:0000642 | |
| HumanPheno | Anomalous trichromacy | 6.37e-04 | 11 | 18 | 2 | HP:0011519 | |
| HumanPheno | Monochromacy | 6.37e-04 | 11 | 18 | 2 | HP:0007803 | |
| HumanPheno | Abnormal posterior segment imaging | 6.55e-04 | 50 | 18 | 3 | HP:0030601 | |
| HumanPheno | Hypokalemic alkalosis | 7.62e-04 | 12 | 18 | 2 | HP:0001949 | |
| HumanPheno | Fetal polyuria | 7.62e-04 | 12 | 18 | 2 | HP:0001563 | |
| Domain | OPSIN | 2.43e-08 | 10 | 63 | 4 | PS00238 | |
| Domain | Opsin_red/grn | 3.66e-08 | 3 | 63 | 3 | IPR000378 | |
| Domain | Opsin | 3.81e-08 | 11 | 63 | 4 | IPR001760 | |
| Domain | G_PROTEIN_RECEP_F1_1 | PROKR1 VN1R5 OPN1MW3 DRD5 OXTR MAS1L AVPR1A AVPR1B AGTR2 OR52N4 RRH OPN1LW GPR135 OPN1MW | 4.94e-08 | 685 | 63 | 14 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | PROKR1 VN1R5 OPN1MW3 DRD5 OXTR MAS1L AVPR1A AVPR1B AGTR2 OR52N4 RRH OPN1LW GPR135 OPN1MW | 5.51e-08 | 691 | 63 | 14 | PS50262 |
| Domain | GPCR_Rhodpsn | PROKR1 VN1R5 OPN1MW3 DRD5 OXTR MAS1L AVPR1A AVPR1B AGTR2 OR52N4 RRH OPN1LW GPR135 OPN1MW | 5.61e-08 | 692 | 63 | 14 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | PROKR1 OPN1MW3 DRD5 OXTR MAS1L AVPR1A AVPR1B AGTR2 OR52N4 RRH OPN1LW GPR135 OPN1MW | 2.91e-07 | 670 | 63 | 13 | IPR017452 |
| Domain | 7tm_1 | PROKR1 OPN1MW3 DRD5 OXTR MAS1L AVPR1A AVPR1B AGTR2 OR52N4 RRH OPN1LW GPR135 OPN1MW | 3.27e-07 | 677 | 63 | 13 | PF00001 |
| Domain | Vasoprsn_rcpt | 3.64e-07 | 5 | 63 | 3 | IPR001817 | |
| Domain | DUF1856 | 1.12e-05 | 2 | 63 | 2 | IPR015076 | |
| Domain | DUF1856 | 1.12e-05 | 2 | 63 | 2 | SM01164 | |
| Domain | DUF1856 | 1.12e-05 | 2 | 63 | 2 | PF08983 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 2.88e-05 | 18 | 63 | 3 | PS00754 | |
| Domain | SNF | 3.41e-05 | 19 | 63 | 3 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 3.41e-05 | 19 | 63 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 3.41e-05 | 19 | 63 | 3 | PS50267 | |
| Domain | Na/ntran_symport | 3.41e-05 | 19 | 63 | 3 | IPR000175 | |
| Domain | AAA+_ATPase | 1.25e-04 | 144 | 63 | 5 | IPR003593 | |
| Domain | AAA | 1.25e-04 | 144 | 63 | 5 | SM00382 | |
| Domain | Retinal_BS | 3.09e-04 | 8 | 63 | 2 | IPR027430 | |
| Domain | ABC_transporter_CS | 3.82e-04 | 42 | 63 | 3 | IPR017871 | |
| Domain | ABC_tran | 5.68e-04 | 48 | 63 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.68e-04 | 48 | 63 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 6.03e-04 | 49 | 63 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 6.40e-04 | 50 | 63 | 3 | IPR003439 | |
| Domain | CD225/Dispanin_fam | 8.53e-04 | 13 | 63 | 2 | IPR007593 | |
| Domain | CD225 | 8.53e-04 | 13 | 63 | 2 | PF04505 | |
| Domain | EGF | 8.65e-04 | 126 | 63 | 4 | PF00008 | |
| Domain | Thioredoxin_CS | 1.47e-03 | 17 | 63 | 2 | IPR017937 | |
| Domain | THIOREDOXIN_1 | 3.20e-03 | 25 | 63 | 2 | PS00194 | |
| Domain | LIPASE_SER | 3.45e-03 | 26 | 63 | 2 | PS00120 | |
| Domain | Thioredoxin | 4.89e-03 | 31 | 63 | 2 | PF00085 | |
| Domain | 7TM_GPCR_Srsx | 6.42e-03 | 112 | 63 | 3 | SM01381 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | OPN1MW2 PROKR1 OPN1MW3 DRD5 OXTR AVPR1A AVPR1B AGTR2 RRH OPN1LW GPR143 | 1.42e-08 | 333 | 49 | 11 | MM14963 |
| Pathway | REACTOME_OPSINS | 2.66e-08 | 10 | 49 | 4 | MM15063 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | PROKR1 DRD5 OXTR AVPR1A AVPR1B AGTR2 RRH OPN1LW GPR143 OPN1MW | 1.58e-07 | 330 | 49 | 10 | M18334 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | OPN1MW2 PROKR1 OPN1MW3 DRD5 OXTR AVPR1A AVPR1B AGTR2 RRH OPN1LW GPR143 | 1.92e-07 | 430 | 49 | 11 | MM15160 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.24e-07 | 186 | 49 | 8 | MM15994 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.32e-07 | 260 | 49 | 9 | M39397 | |
| Pathway | WP_GPCRS_NONODORANT | 2.81e-07 | 266 | 49 | 9 | MM15843 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 7.84e-07 | 6 | 49 | 3 | M27289 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 7.84e-07 | 6 | 49 | 3 | MM14989 | |
| Pathway | WP_GPCRS_OTHER | 9.41e-07 | 96 | 49 | 6 | MM15939 | |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 2.18e-06 | 8 | 49 | 3 | MM14880 | |
| Pathway | REACTOME_OPSINS | 3.27e-06 | 9 | 49 | 3 | M6285 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | PROKR1 DRD5 OXTR AVPR1A AVPR1B AGTR2 RRH OPN1LW GPR143 OPN1MW | 3.45e-06 | 463 | 49 | 10 | M507 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | OPN1MW2 PROKR1 OPN1MW3 DRD5 OXTR AVPR1A AVPR1B AGTR2 RRH OPN1LW GPR143 | 1.02e-05 | 646 | 49 | 11 | MM14962 |
| Pathway | WP_GPCRS_PEPTIDE | 9.98e-05 | 70 | 49 | 4 | MM15959 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | PROKR1 DRD5 OXTR AVPR1A AVPR1B AGTR2 RRH OPN1LW GPR143 OPN1MW | 1.24e-04 | 702 | 49 | 10 | M746 |
| Pathway | WP_PEPTIDE_GPCRS | 1.31e-04 | 75 | 49 | 4 | M39696 | |
| Pathway | WP_GPCRS_ODORANT | 2.06e-04 | 157 | 49 | 5 | MM15872 | |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 2.46e-04 | 7 | 49 | 2 | M27157 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.73e-04 | 44 | 49 | 3 | M11911 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 5.86e-04 | 197 | 49 | 5 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 5.86e-04 | 197 | 49 | 5 | MM14970 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 6.90e-04 | 50 | 49 | 3 | M47951 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 7.83e-04 | 210 | 49 | 5 | MM15043 | |
| Pathway | REACTOME_RETINOID_CYCLE_DISEASE_EVENTS | 9.01e-04 | 13 | 49 | 2 | M29612 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.07e-04 | 217 | 49 | 5 | M18437 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.56e-03 | 17 | 49 | 2 | MM14552 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.75e-03 | 18 | 49 | 2 | M524 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.95e-03 | 19 | 49 | 2 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.95e-03 | 19 | 49 | 2 | MM15107 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.46e-03 | 272 | 49 | 5 | M13380 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 3.19e-03 | 289 | 49 | 5 | MM15057 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 3.28e-03 | 177 | 49 | 4 | M27476 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.34e-03 | 178 | 49 | 4 | M2890 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.58e-03 | 736 | 49 | 8 | M27287 | |
| Pubmed | Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy. | 1.11e-11 | 4 | 65 | 4 | 29386880 | |
| Pubmed | Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. | 5.55e-11 | 5 | 65 | 4 | 12486173 | |
| Pubmed | Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. | 5.55e-11 | 5 | 65 | 4 | 2937147 | |
| Pubmed | Multiple hypothalamic cell populations encoding distinct visual information. | 6.23e-09 | 3 | 65 | 3 | 21224225 | |
| Pubmed | Circadian Regulation of the Rod Contribution to Mesopic Vision in Mice. | 6.23e-09 | 3 | 65 | 3 | 36216501 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 34111401 | ||
| Pubmed | Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy. | 6.23e-09 | 3 | 65 | 3 | 28751656 | |
| Pubmed | The molecular genetics and evolution of red and green color vision in vertebrates. | 6.23e-09 | 3 | 65 | 3 | 11545071 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 38900750 | ||
| Pubmed | Co-expression of murine opsins facilitates identifying the site of cone adaptation. | 6.23e-09 | 3 | 65 | 3 | 12511072 | |
| Pubmed | Molecular determinants of human red/green color discrimination. | 6.23e-09 | 3 | 65 | 3 | 8185948 | |
| Pubmed | X-linked cone dystrophy caused by mutation of the red and green cone opsins. | 6.23e-09 | 3 | 65 | 3 | 20579627 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 38410159 | ||
| Pubmed | Chloride-dependent spectral tuning mechanism of L-group cone visual pigments. | 6.23e-09 | 3 | 65 | 3 | 23350963 | |
| Pubmed | Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. | 6.23e-09 | 3 | 65 | 3 | 20471354 | |
| Pubmed | Spectral tuning of a circadian photopigment in a subterranean 'blind' mammal (Spalax ehrenbergi). | 6.23e-09 | 3 | 65 | 3 | 10567724 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 14500905 | ||
| Pubmed | Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy. | 6.23e-09 | 3 | 65 | 3 | 31469404 | |
| Pubmed | Mechanisms of spectral tuning in the mouse green cone pigment. | 6.23e-09 | 3 | 65 | 3 | 9238068 | |
| Pubmed | Emergence of novel color vision in mice engineered to express a human cone photopigment. | 6.23e-09 | 3 | 65 | 3 | 17379811 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 7958444 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 28103478 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 11955056 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 3303660 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 26438865 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 17249565 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 38060327 | ||
| Pubmed | Contribution of M-opsin-based color vision to refractive development in mice. | 2.49e-08 | 4 | 65 | 3 | 34126082 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 31461375 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 8088841 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 31846668 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 16567464 | ||
| Pubmed | S-opsin knockout mice with the endogenous M-opsin gene replaced by an L-opsin variant. | 2.49e-08 | 4 | 65 | 3 | 24801621 | |
| Pubmed | Melanopsin Contributions to the Representation of Images in the Early Visual System. | 2.49e-08 | 4 | 65 | 3 | 28528909 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 25308073 | ||
| Pubmed | Using Silent Substitution to Track the Mesopic Transition From Rod- to Cone-Based Vision in Mice. | 6.21e-08 | 5 | 65 | 3 | 26818794 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 22090509 | ||
| Pubmed | Peripherin-2 differentially interacts with cone opsins in outer segments of cone photoreceptors. | 6.21e-08 | 5 | 65 | 3 | 27033727 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 11055434 | ||
| Pubmed | Oxytocin Facilitates Allomaternal Behavior under Stress in Laboratory Mice. | 6.21e-08 | 5 | 65 | 3 | 35017259 | |
| Pubmed | Noncoding Mutations in a Thyroid Hormone Receptor Gene That Impair Cone Photoreceptor Function. | 6.21e-08 | 5 | 65 | 3 | 36631163 | |
| Pubmed | A common integration locus in type B retrovirus-induced thymic lymphomas. | 6.21e-08 | 5 | 65 | 3 | 1333116 | |
| Pubmed | Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. | 6.21e-08 | 5 | 65 | 3 | 10723722 | |
| Pubmed | Oxytocin signaling in the medial amygdala is required for sex discrimination of social cues. | 6.21e-08 | 5 | 65 | 3 | 29231812 | |
| Pubmed | Melanopsin-based brightness discrimination in mice and humans. | 6.21e-08 | 5 | 65 | 3 | 22633808 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 24058409 | ||
| Pubmed | Variations in photoreceptor throughput to mouse visual cortex and the unique effects on tuning. | 6.21e-08 | 5 | 65 | 3 | 34099749 | |
| Pubmed | 9.83e-08 | 200 | 65 | 7 | 18240029 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 10858434 | ||
| Pubmed | Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71. | 1.24e-07 | 6 | 65 | 3 | 8872469 | |
| Pubmed | A thyroid hormone receptor that is required for the development of green cone photoreceptors. | 1.24e-07 | 6 | 65 | 3 | 11138006 | |
| Pubmed | Functional comparison of rod and cone Gα(t) on the regulation of light sensitivity. | 1.24e-07 | 6 | 65 | 3 | 23288843 | |
| Pubmed | Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. | 1.24e-07 | 6 | 65 | 3 | 10395695 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 17436273 | ||
| Pubmed | Telomere-related markers for the pseudoautosomal region of the mouse genome. | 1.24e-07 | 6 | 65 | 3 | 1549575 | |
| Pubmed | Calcitonin receptor signaling in the medial preoptic area enables risk-taking maternal care. | 2.17e-07 | 7 | 65 | 3 | 34077719 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 18199774 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 8378320 | ||
| Pubmed | Rod Photoreceptor Activation Alone Defines the Release of Dopamine in the Retina. | 2.17e-07 | 7 | 65 | 3 | 30799247 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 16574740 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 19332056 | ||
| Pubmed | Retarded developmental expression and patterning of retinal cone opsins in hypothyroid mice. | 2.17e-07 | 7 | 65 | 3 | 18974269 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 8001979 | ||
| Pubmed | Mapping of the murine tbl1 gene reveals a new rearrangement between mouse and human X Chromosomes. | 2.17e-07 | 7 | 65 | 3 | 9880679 | |
| Pubmed | Rods progressively escape saturation to drive visual responses in daylight conditions. | 2.17e-07 | 7 | 65 | 3 | 29180667 | |
| Pubmed | Localization of the mdx mutation within the mouse dystrophin gene. | 3.47e-07 | 8 | 65 | 3 | 2903046 | |
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 1572654 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 21813673 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 31163126 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 20203194 | ||
| Pubmed | Tubby is required for trafficking G protein-coupled receptors to neuronal cilia. | 3.47e-07 | 8 | 65 | 3 | 23351594 | |
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 10725384 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 33007388 | ||
| Pubmed | Linkage of amelogenin (Amel) to the distal portion of the mouse X chromosome. | 3.47e-07 | 8 | 65 | 3 | 1675194 | |
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 3416629 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 12651948 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 16043864 | ||
| Pubmed | Visuomotor anomalies in achiasmatic mice expressing a transfer-defective Vax1 mutant. | 3.84e-07 | 32 | 65 | 4 | 36737666 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 21850176 | ||
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 28370415 | ||
| Pubmed | IFT20 is required for opsin trafficking and photoreceptor outer segment development. | 5.19e-07 | 9 | 65 | 3 | 21307337 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 2906327 | ||
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 1973136 | ||
| Pubmed | Retinal dystrophy resulting from ablation of RXR alpha in the mouse retinal pigment epithelium. | 5.19e-07 | 9 | 65 | 3 | 14742273 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 25296752 | ||
| Pubmed | Comparative mapping of the actin-binding protein 280 genes in human and mouse. | 5.19e-07 | 9 | 65 | 3 | 8088838 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 27669145 | ||
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 12407160 | ||
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 8449515 | ||
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 32236127 | ||
| Pubmed | Mapping of the phosphorylase kinase alpha subunit gene on the mouse X chromosome. | 7.41e-07 | 10 | 65 | 3 | 1973380 | |
| Pubmed | Mapping of ornithine aminotransferase gene sequences to mouse chromosomes 7, X, and 3. | 7.41e-07 | 10 | 65 | 3 | 1349842 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.41e-07 | 10 | 65 | 3 | 8857542 | |
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 1964443 | ||
| Pubmed | Vax2 regulates retinoic acid distribution and cone opsin expression in the vertebrate eye. | 7.41e-07 | 10 | 65 | 3 | 21148184 | |
| Pubmed | Fam151b, the mouse homologue of C.elegans menorin gene, is essential for retinal function. | 7.41e-07 | 10 | 65 | 3 | 31949211 | |
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 1684949 | ||
| Pubmed | 1.02e-06 | 11 | 65 | 3 | 1572636 | ||
| Pubmed | 1.02e-06 | 11 | 65 | 3 | 24421398 | ||
| Pubmed | 1.35e-06 | 12 | 65 | 3 | 1679744 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 2.44e-04 | 213 | 65 | 4 | chrXq28 | |
| Cytoband | Xq28 | 2.03e-03 | 176 | 65 | 3 | Xq28 | |
| Cytoband | 14q23.1 | 2.05e-03 | 47 | 65 | 2 | 14q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 5.69e-03 | 503 | 65 | 4 | chr6p21 | |
| Cytoband | 6p21.1 | 5.81e-03 | 80 | 65 | 2 | 6p21.1 | |
| GeneFamily | Opsin receptors | 3.47e-11 | 11 | 45 | 5 | 215 | |
| GeneFamily | Arginine vasopressin and oxytocin receptors | 5.75e-08 | 4 | 45 | 3 | 259 | |
| GeneFamily | Protein disulfide isomerases | 1.23e-03 | 21 | 45 | 2 | 692 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.61e-02 | 78 | 45 | 2 | 262 | |
| GeneFamily | Solute carriers | 1.65e-02 | 395 | 45 | 4 | 752 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.85e-06 | 141 | 64 | 5 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-06 | 184 | 64 | 5 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 187 | 64 | 5 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-06 | 188 | 64 | 5 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 191 | 64 | 5 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 191 | 64 | 5 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-06 | 195 | 64 | 5 | f7d9adadd37209ce1a38e5d621607b9c9270fed8 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 113 | 64 | 4 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 113 | 64 | 4 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.13e-05 | 113 | 64 | 4 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-05 | 132 | 64 | 4 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.41e-05 | 136 | 64 | 4 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.80e-05 | 152 | 64 | 4 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.15e-05 | 154 | 64 | 4 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 159 | 64 | 4 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 160 | 64 | 4 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 160 | 64 | 4 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Fos_(iSPN,_IEG+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.43e-05 | 59 | 64 | 3 | a72de8cda377c87fa9a6fbda72735d850650f9f4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Fos_(iSPN,_IEG+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.43e-05 | 59 | 64 | 3 | 3ab024fa7a927177da0dc764cee46dabdd008040 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-05 | 161 | 64 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 163 | 64 | 4 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.91e-05 | 163 | 64 | 4 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 163 | 64 | 4 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.12e-05 | 164 | 64 | 4 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.34e-05 | 165 | 64 | 4 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 167 | 64 | 4 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 167 | 64 | 4 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 173 | 64 | 4 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 173 | 64 | 4 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 174 | 64 | 4 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 174 | 64 | 4 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 174 | 64 | 4 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 174 | 64 | 4 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-04 | 175 | 64 | 4 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 175 | 64 | 4 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-04 | 175 | 64 | 4 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.22e-04 | 177 | 64 | 4 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 177 | 64 | 4 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.22e-04 | 177 | 64 | 4 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 64 | 4 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 181 | 64 | 4 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 182 | 64 | 4 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 184 | 64 | 4 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | RSV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 1.42e-04 | 184 | 64 | 4 | 1e282d619ef8035437fabe0fd2aefda1c142f7f6 | |
| ToppCell | RSV-Healthy-5|RSV / Virus stimulation, Condition and Cluster | 1.42e-04 | 184 | 64 | 4 | ba958f731de6c9eff60103d483e020e2c0c7af7c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 184 | 64 | 4 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-04 | 186 | 64 | 4 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 186 | 64 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 186 | 64 | 4 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 187 | 64 | 4 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 64 | 4 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 190 | 64 | 4 | bb3b396d78887d5d6f93a05c8ed4d703591bf33f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 190 | 64 | 4 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | f631749ef1f2270133664cf5eb4cf545a8482bd3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | feec8617678b778475747ad406c80231e07fd6f7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 192 | 64 | 4 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 64 | 4 | a516839871c4e9683093a1c07b72c682f9ecbb3d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 194 | 64 | 4 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 194 | 64 | 4 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 194 | 64 | 4 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 64 | 4 | 6165c00ec06a8393f23b0c62f679c143839b03b1 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-04 | 195 | 64 | 4 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 195 | 64 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 195 | 64 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.77e-04 | 195 | 64 | 4 | ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 195 | 64 | 4 | 717e6a66bad50e711442d71360b540789646b334 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 195 | 64 | 4 | 10774b5ce17d4edd23dbf4709b11cc87cc2b87be | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-04 | 196 | 64 | 4 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.81e-04 | 196 | 64 | 4 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.86e-04 | 77 | 64 | 3 | 7bb18406d404c51ee938cc577c155dc51868ddb9 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.86e-04 | 77 | 64 | 3 | ac311740424ff75b478b3c19fa0fae93776eb54e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.86e-04 | 77 | 64 | 3 | 9f2dbf922acb905d636427a766a217c0db9671d2 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.86e-04 | 77 | 64 | 3 | afe990041849a68fd75e0c11b633a7b90fefade1 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.86e-04 | 77 | 64 | 3 | ec8f625cae561986ed27dfaefa8f822dd1c4fba1 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.86e-04 | 77 | 64 | 3 | af7e1e76db33b115238b6fc61fc0dd86aab8e49d | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.88e-04 | 198 | 64 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 78 | 64 | 3 | c3360f02624a84930f8b44e12bb6b9aa8284ddc7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.95e-04 | 200 | 64 | 4 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.95e-04 | 200 | 64 | 4 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-04 | 200 | 64 | 4 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-04 | 200 | 64 | 4 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.95e-04 | 200 | 64 | 4 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.95e-04 | 90 | 64 | 3 | 27865bd63dda0624e62a3b713464a490b588d3ae | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.95e-04 | 90 | 64 | 3 | 8c2eb7444f938faade7c81a60c004252d588c80b | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.95e-04 | 90 | 64 | 3 | 4bc53b521abb79fc53ac912f1dc2e3c55426b2e0 | |
| Drug | A-26 | 7.61e-09 | 25 | 64 | 5 | CID000037120 | |
| Drug | Mtpia-oxytocin | 2.12e-08 | 3 | 64 | 3 | CID003083145 | |
| Drug | Phpc-1,2 | 2.11e-07 | 5 | 64 | 3 | CID000173570 | |
| Drug | 14-fluororetinal | 2.11e-07 | 5 | 64 | 3 | CID006438634 | |
| Drug | 10,20-methanoretinal | 2.11e-07 | 5 | 64 | 3 | CID006438558 | |
| Drug | trans-retinoyl chloromethane | 2.11e-07 | 5 | 64 | 3 | CID006439860 | |
| Drug | 9,11-dcfr | 2.11e-07 | 5 | 64 | 3 | CID006443659 | |
| Drug | L-366,509 | 4.21e-07 | 6 | 64 | 3 | CID003083288 | |
| Drug | L-371,257 | 4.21e-07 | 6 | 64 | 3 | CID006918320 | |
| Drug | 3-hydroxyretinal | 4.21e-07 | 6 | 64 | 3 | CID000151436 | |
| Drug | 7,8-Dhr | 4.21e-07 | 6 | 64 | 3 | CID006443426 | |
| Drug | Hydrin 2 | 4.21e-07 | 6 | 64 | 3 | CID005008461 | |
| Drug | AC1NTD7Z | 4.21e-07 | 6 | 64 | 3 | CID005378594 | |
| Drug | 5,6-epoxy-3-dehydroretinal | 4.21e-07 | 6 | 64 | 3 | CID006449988 | |
| Drug | Vdavp | 7.35e-07 | 7 | 64 | 3 | CID000171113 | |
| Drug | 4-n-butylaniline | 7.35e-07 | 7 | 64 | 3 | CID000007694 | |
| Drug | naphthalene-diisocyanate | 8.56e-07 | 62 | 64 | 5 | CID003033874 | |
| Drug | hydrochlorothiazide | 1.10e-06 | 120 | 64 | 6 | CID000003639 | |
| Drug | A1-E | 1.17e-06 | 66 | 64 | 5 | CID005326966 | |
| Drug | DDAVP | 1.28e-06 | 123 | 64 | 6 | CID000027991 | |
| Drug | AC1MIZWH | 1.76e-06 | 9 | 64 | 3 | CID003083001 | |
| Drug | Hydrin 1 | 1.76e-06 | 9 | 64 | 3 | CID000195374 | |
| Drug | Photoproduct | 3.44e-06 | 11 | 64 | 3 | CID000500521 | |
| Drug | retinal oxime | 3.44e-06 | 11 | 64 | 3 | CID009577279 | |
| Drug | Dpmetyravp | 3.44e-06 | 11 | 64 | 3 | CID000119517 | |
| Drug | L-368,899 | 3.44e-06 | 11 | 64 | 3 | CID000132857 | |
| Drug | OPC-31260 | 3.90e-06 | 38 | 64 | 4 | CID000119369 | |
| Drug | Proxyl-opc | 7.08e-06 | 44 | 64 | 4 | CID000124490 | |
| Drug | AC1L28XQ | 7.54e-06 | 14 | 64 | 3 | CID000068054 | |
| Drug | Ovta | 7.54e-06 | 14 | 64 | 3 | CID003081047 | |
| Drug | Utedrin | 7.54e-06 | 14 | 64 | 3 | CID000005771 | |
| Drug | Gliclazide | 7.78e-06 | 2 | 64 | 2 | DB01120 | |
| Drug | vasopressin | 1.27e-05 | 388 | 64 | 8 | CID011979316 | |
| Drug | atosiban | 1.40e-05 | 17 | 64 | 3 | CID000068613 | |
| Drug | alinidine | 1.40e-05 | 17 | 64 | 3 | CID000036354 | |
| Drug | N-methyl-DL-alanine | 1.40e-05 | 17 | 64 | 3 | CID000004377 | |
| Drug | SR 49059 | 1.99e-05 | 19 | 64 | 3 | CID000060943 | |
| Drug | OPC-21268 | 1.99e-05 | 19 | 64 | 3 | CID000114904 | |
| Drug | Vasopressin | 2.33e-05 | 3 | 64 | 2 | DB00067 | |
| Drug | Terlipressin | 2.33e-05 | 3 | 64 | 2 | DB02638 | |
| Drug | Desmopressin | 2.33e-05 | 3 | 64 | 2 | DB00035 | |
| Drug | Dvdavp | 2.33e-05 | 20 | 64 | 3 | CID006441676 | |
| Drug | 2-amino-5-oxohexanoate | 3.65e-05 | 133 | 64 | 5 | CID000440805 | |
| Drug | AC1L8WBM | 3.92e-05 | 135 | 64 | 5 | CID000388647 | |
| Drug | D-Mlvp | 4.65e-05 | 4 | 64 | 2 | CID003083074 | |
| Drug | Ac-VP | 4.65e-05 | 4 | 64 | 2 | CID000149364 | |
| Drug | conivaptan | 4.66e-05 | 25 | 64 | 3 | CID000151171 | |
| Drug | 4-Ser-8-ile-oxytocin | 5.90e-05 | 27 | 64 | 3 | CID000123960 | |
| Drug | Mesotocin | 7.35e-05 | 29 | 64 | 3 | CID000123799 | |
| Drug | Alvp | 7.74e-05 | 5 | 64 | 2 | CID003083235 | |
| Drug | Tgot | 7.74e-05 | 5 | 64 | 2 | CID003082106 | |
| Drug | AGN 190851 | 7.74e-05 | 5 | 64 | 2 | CID000131829 | |
| Drug | AC1MJ5J4 | 7.74e-05 | 5 | 64 | 2 | CID003086072 | |
| Drug | BRL 53117 | 7.74e-05 | 5 | 64 | 2 | CID000133023 | |
| Drug | Mcppa-avp | 8.15e-05 | 30 | 64 | 3 | CID000105077 | |
| Drug | dinophysistoxin-1 | 9.00e-05 | 31 | 64 | 3 | CID006437058 | |
| Drug | PS-b | 1.09e-04 | 33 | 64 | 3 | CID000448408 | |
| Drug | tolvaptan | 1.09e-04 | 33 | 64 | 3 | CID000216237 | |
| Drug | DMHP | 1.16e-04 | 6 | 64 | 2 | CID000036276 | |
| Drug | D3PVP | 1.16e-04 | 6 | 64 | 2 | CID000195824 | |
| Drug | AC1LAN8A | 1.16e-04 | 6 | 64 | 2 | CID000516730 | |
| Drug | angiotensin | 1.41e-04 | 282 | 64 | 6 | CID003083715 | |
| Drug | AC1L1CHL | 1.55e-04 | 96 | 64 | 4 | CID000001902 | |
| Drug | phenyl-N-acetyl-alpha-D-glucosaminide | 1.62e-04 | 7 | 64 | 2 | CID000082399 | |
| Drug | Opc51803 | 1.62e-04 | 7 | 64 | 2 | CID003038506 | |
| Drug | C12063 | 1.98e-04 | 429 | 64 | 7 | CID005282055 | |
| Drug | capecitabine | 2.11e-04 | 104 | 64 | 4 | CID000060953 | |
| Drug | AC1Q1ZY1 | 2.15e-04 | 8 | 64 | 2 | CID000065964 | |
| Drug | AL-3138 | 2.15e-04 | 8 | 64 | 2 | CID005311237 | |
| Drug | L 366948 | 2.15e-04 | 8 | 64 | 2 | CID000188397 | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3454_DN | |
| Drug | LDAO | 2.25e-04 | 42 | 64 | 3 | CID000015433 | |
| Drug | N-N-C | 2.25e-04 | 42 | 64 | 3 | CID005278688 | |
| Drug | Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 5504_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.27e-04 | 196 | 64 | 5 | 4972_DN | |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 7464_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 1694_UP | |
| Drug | Pyoverdin | 2.41e-04 | 43 | 64 | 3 | CID005289234 | |
| Drug | GTP[S] | 2.42e-04 | 591 | 64 | 8 | CID000001764 | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; HL60; HT_HG-U133A | 2.43e-04 | 199 | 64 | 5 | 2470_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.49e-04 | 200 | 64 | 5 | 2575_UP | |
| Drug | fentanyl | 2.71e-04 | 111 | 64 | 4 | CID000003345 | |
| Drug | CGS 22652 | 2.76e-04 | 9 | 64 | 2 | CID000131717 | |
| Drug | d(CH2)5-Davp | 2.76e-04 | 9 | 64 | 2 | CID000123750 | |
| Drug | Aerosols | 2.76e-04 | 9 | 64 | 2 | ctd:D000336 | |
| Drug | Mcp-tva-argipressin | 2.76e-04 | 9 | 64 | 2 | CID000122322 | |
| Drug | amoxapine | 2.95e-04 | 46 | 64 | 3 | CID000002170 | |
| Drug | Lypressin | 3.14e-04 | 47 | 64 | 3 | CID000005772 | |
| Drug | chlorpropamide | 3.35e-04 | 48 | 64 | 3 | CID000002727 | |
| Drug | cyclo(Leu-Gly) | 3.45e-04 | 10 | 64 | 2 | CID000002902 | |
| Drug | AC1MIWZV | 3.45e-04 | 10 | 64 | 2 | CID003081474 | |
| Drug | AC1L63MU | 4.28e-04 | 347 | 64 | 6 | CID000285703 | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 1.77e-11 | 4 | 62 | 4 | DOID:0050679 (implicated_via_orthology) | |
| Disease | brain edema (implicated_via_orthology) | 1.76e-07 | 6 | 62 | 3 | DOID:4724 (implicated_via_orthology) | |
| Disease | Cone monochromatism | 4.34e-06 | 2 | 62 | 2 | C0339537 | |
| Disease | carotid stenosis (is_marker_for) | 4.34e-06 | 2 | 62 | 2 | DOID:13001 (is_marker_for) | |
| Disease | BLUE CONE MONOCHROMACY | 4.34e-06 | 2 | 62 | 2 | 303700 | |
| Disease | Cone monochromatism | 4.34e-06 | 2 | 62 | 2 | cv:C0339537 | |
| Disease | blue cone monochromacy (is_implicated_in) | 4.34e-06 | 2 | 62 | 2 | DOID:0050679 (is_implicated_in) | |
| Disease | Bartter disease (is_implicated_in) | 4.34e-06 | 2 | 62 | 2 | DOID:445 (is_implicated_in) | |
| Disease | BORNHOLM EYE DISEASE | 4.34e-06 | 2 | 62 | 2 | C3159311 | |
| Disease | Achromatopsia incomplete, X-linked | 4.34e-06 | 2 | 62 | 2 | C2931753 | |
| Disease | Red-green dyschromatopsia | 4.34e-06 | 2 | 62 | 2 | cv:C0155016 | |
| Disease | Bartter Disease | 4.33e-05 | 5 | 62 | 2 | C0004775 | |
| Disease | Bartter syndrome | 6.48e-05 | 6 | 62 | 2 | cv:C0004775 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 8.26e-05 | 40 | 62 | 3 | EFO_0004746 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.12e-04 | 225 | 62 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | angina pectoris | 1.42e-04 | 125 | 62 | 4 | EFO_0003913 | |
| Disease | total lipids in lipoprotein particles measurement | 1.43e-04 | 48 | 62 | 3 | EFO_0022309 | |
| Disease | coronary artery disease | 1.79e-04 | 1194 | 62 | 10 | EFO_0001645 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.20e-04 | 260 | 62 | 5 | EFO_0008317 | |
| Disease | imidazole lactate measurement | 3.34e-04 | 13 | 62 | 2 | EFO_0800004 | |
| Disease | total lipids in very large HDL measurement | 3.68e-04 | 66 | 62 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 3.68e-04 | 66 | 62 | 3 | EFO_0022298 | |
| Disease | coronary artery disease (is_marker_for) | 3.85e-04 | 67 | 62 | 3 | DOID:3393 (is_marker_for) | |
| Disease | rheumatoid arthritis (is_marker_for) | 4.19e-04 | 69 | 62 | 3 | DOID:7148 (is_marker_for) | |
| Disease | high density lipoprotein particle size measurement | 4.57e-04 | 170 | 62 | 4 | EFO_0008592 | |
| Disease | phospholipids in large HDL measurement | 4.95e-04 | 73 | 62 | 3 | EFO_0022190 | |
| Disease | total lipids in large HDL | 5.15e-04 | 74 | 62 | 3 | EFO_0022189 | |
| Disease | free cholesterol in large HDL measurement | 6.23e-04 | 79 | 62 | 3 | EFO_0022157 | |
| Disease | linoleic acid measurement | 6.41e-04 | 186 | 62 | 4 | EFO_0006807 | |
| Disease | cholesterol in large HDL measurement | 6.47e-04 | 80 | 62 | 3 | EFO_0021900 | |
| Disease | HMG CoA reductase inhibitor use measurement | 6.81e-04 | 189 | 62 | 4 | EFO_0009932 | |
| Disease | cerebral infarction (is_marker_for) | 7.26e-04 | 19 | 62 | 2 | DOID:3526 (is_marker_for) | |
| Disease | metabolic syndrome | 8.40e-04 | 200 | 62 | 4 | EFO_0000195 | |
| Disease | myocardial infarction | 8.49e-04 | 350 | 62 | 5 | EFO_0000612 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.10e-03 | 215 | 62 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | Coronary heart disease | 1.16e-03 | 24 | 62 | 2 | C0010068 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.20e-03 | 220 | 62 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | obsessive-compulsive disorder | 1.24e-03 | 100 | 62 | 3 | EFO_0004242 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.24e-03 | 222 | 62 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | paracentral lobule volume measurement | 1.26e-03 | 25 | 62 | 2 | EFO_0010317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.28e-03 | 224 | 62 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 1.38e-03 | 104 | 62 | 3 | EFO_0008591, EFO_0008595 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.62e-03 | 239 | 62 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | Cone-Rod Dystrophy 2 | 1.70e-03 | 29 | 62 | 2 | C3489532 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.72e-03 | 243 | 62 | 4 | EFO_0004612, EFO_0020944 | |
| Disease | proteinuria (implicated_via_orthology) | 1.82e-03 | 30 | 62 | 2 | DOID:576 (implicated_via_orthology) | |
| Disease | intellectual disability (is_implicated_in) | 1.82e-03 | 30 | 62 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | IgA glomerulonephritis (is_implicated_in) | 1.82e-03 | 30 | 62 | 2 | DOID:2986 (is_implicated_in) | |
| Disease | JT interval | 1.85e-03 | 248 | 62 | 4 | EFO_0007885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCPVVYCSIVYWMTG | 481 | Q9H172 | |
| GPFLVYCNMTADAAW | 616 | Q9BZ76 | |
| YMCLPANWTGTCTLV | 346 | Q9N2K0 | |
| YMCLPANWTGTCTLV | 346 | Q9N2J8 | |
| LVWCMACLSSLPTFY | 166 | P50052 | |
| NRWNMYLCECPLRFG | 1666 | Q9NYQ6 | |
| MCVFASFGLCSPEIW | 491 | Q6ZPD9 | |
| VVMIFAYCVCWGPYT | 271 | P04000 | |
| VVMVLAFCFCWGPYA | 271 | P0DN78 | |
| MYLSICCCFLLWAPA | 1 | O14917 | |
| IMGVFVCCWLPFFIL | 301 | P21918 | |
| ICMFLVAWSPYSIVC | 246 | O14718 | |
| VVMVLAFCFCWGPYA | 271 | P0DN77 | |
| QLWISFPFCSMYVVA | 26 | Q8NGI2 | |
| VNAWAMFHCTCNPGY | 231 | O95460 | |
| MTDICRSCGFWPGYL | 976 | Q9UPZ3 | |
| WIMILECGYTYCSIN | 666 | Q63HM2 | |
| LMVGCWFASVYIVCQ | 211 | A6NFY4 | |
| MSNSVPLLCFWSLCY | 1 | Q9Y5X9 | |
| GCWQPLCKSYFPYLM | 26 | Q6UX53 | |
| WYINCFGCETHAMLP | 326 | P06744 | |
| NSCCNPWIYMLFTGH | 321 | P30559 | |
| FLMGCYDPGSQKWCT | 711 | P49916 | |
| CGCPLYWKAPMFRAA | 756 | Q06190 | |
| GWNPSVCMNFCAAFL | 321 | O77932 | |
| VFWLLCCGATNPYMV | 96 | P35410 | |
| CLCGCLAVVYPFDWQ | 11 | Q13093 | |
| VVMVLAFCFCWGPYA | 271 | P04001 | |
| FPMNETFCCLWIACV | 11 | Q5VYJ5 | |
| CFCPMWPVNIVAFAY | 276 | Q7Z6L0 | |
| MFPSLVNCCTIDWFV | 2591 | Q9C0G6 | |
| MIVFVICCWGPYCFL | 336 | Q8IZ08 | |
| IGGIIWSMCQCYPKI | 46 | Q8WZ55 | |
| WSMCQCYPKITFVPA | 51 | Q8WZ55 | |
| CCHAMVALIYPFAWQ | 781 | Q9ULE3 | |
| CVGSAMWIQLLYSAC | 116 | P51810 | |
| VWDMLNYLVPATCCV | 1841 | Q9BZC7 | |
| CFTMDPSIRWEYCNL | 1676 | P08519 | |
| CPQRWAMAEGYGACL | 116 | O95620 | |
| VDFYSPWCHPCQVLM | 581 | Q8IXB1 | |
| IVVDAMCCLRYWYTP | 41 | Q96EK7 | |
| EESSFWLPLYGNMCC | 261 | Q8IZC4 | |
| WLPLYGNMCCRLVAQ | 266 | Q8IZC4 | |
| YSWAVITPVLCVGCF | 506 | P31641 | |
| PFFLCWCLVGAFMIN | 271 | Q9GZN6 | |
| FGAVLCCAVMFVINW | 611 | Q13621 | |
| MCVQATWLCGEPGPY | 506 | A4QPH2 | |
| AIQMIYWCPESRIFC | 516 | Q9Y2K9 | |
| NCCVQIMGGYFTWTP | 676 | Q09428 | |
| LMCILTAYVLCWAPF | 286 | Q8TCW9 | |
| LRAWFASEQMICPYC | 4021 | Q63HN8 | |
| MLKFYAPWCPSCQQT | 56 | Q9H1E5 | |
| LGNLNSCCNPWIYMG | 326 | P47901 | |
| SCCNPWIYMGFNSHL | 331 | P47901 | |
| LGMKCWYHSVFACPI | 326 | Q96G75 | |
| SGERPFVCNWMYCGK | 646 | Q02447 | |
| AFWCLVQICEVYLPG | 196 | Q8IV04 | |
| VVMLPFSPLWACCFF | 366 | Q9NSD5 | |
| QGPVWCLCVYSMGDL | 396 | Q6Q0C0 | |
| IRFEMPYNIWCDGCK | 46 | P13994 | |
| YLSCMGFPECRSAVW | 676 | Q13472 | |
| LGSLNSCCNPWIYMF | 336 | P37288 | |
| SWVLNMFIGVIFCCT | 171 | Q7Z5H4 | |
| CEGPRMLSWCPFYKV | 31 | Q5TGU0 | |
| CMEVAGQSWCIPFYL | 696 | Q01118 | |
| MCYRWLASEGICFPD | 541 | Q9C0I4 | |
| KSWSVYVGARCCLMP | 161 | P15692 | |
| PRVPIMCWGSCAYTI | 1326 | Q8IWV8 | |
| YCGLCAAWFNNPLMA | 146 | Q9H898 | |
| FSMLCCFWPVGIAAF | 101 | Q6ZNR0 | |
| CPFWGCFSQLMLYAE | 26 | Q96IK0 |